1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Romero Ferro J, Gil Martínez L, Sánchez Asensio A, Cortina García JI, García-Madrona S, Matute C, Cruz-Culebras A, Masjuan J, Suárez Robles M, Vera Lechuga R, de Felipe A.

    Teaching NeuroImages: Syphilitic Aortitis Presenting as Aortic Arch Thrombus and Acute Ischemic Stroke.

    NEUROLOGY . 106(8): .

    [doi:10.1212/WNL.0000000000214868]

  • Norman FF, Huits R, Chen LH.

    Dengue in a warming world: changing epidemiology, vaccines, and therapeutic developments.

    Expert Review of Anti-Infective Therapy . 24(4): 363-380.

    [doi:10.1080/14787210.2026.2662312]

  • Manzano M, Moreno E, Martín-Pedraza L, Díaz-García C, Moreno S, Navia B, Serrano-Villar S.

    Mediterranean diet adherence is associated with antiviral, neuroimmune, and cardiometabolic proteomic profiles in people with HIV.

    Frontiers in Nutrition . 13: 1801654-1801654.

    [doi:10.3389/fnut.2026.1801654]

  • Rosas Cancio-Suárez M, Moreno A, Terrón SDC, Vivancos MJ, Vélez Díaz-Pallarés M, Casado JL, Cano C, Navarro-Soler R, Moreno S, Pérez-Elías MJ.

    Neuropsychiatric Tolerability of Long-Acting Cabotegravir and Rilpivirine in People With HIV With Prior INSTI-Related CNS Toxicity: A Real-World Cohort Study.

    Open Forum Infectious Diseases . 13(4): .

    [doi:10.1093/ofid/ofag210]

  • Arsuaga M, Oliveira I, Sánchez-Montalvá A, De la Calle-Prieto F, Pou D, Chamorro S, Goikoetxea J, Hernández-Jiménez P, Torrús D, De Miguel-Buckley R, Perez-Molina JA, Díaz-Menéndez M.

    Travel Health Risks in Adults Over 60 Years of Age: Insights from the +Redivi Network in Spain.

    JOURNAL OF TRAVEL MEDICINE . 33(3): .

    [doi:10.1093/jtm/taag011]

  • Llenas-García J, Arcos Rueda MDM, Calderón Hernaiz R, Pedrero Tomé R, Bisbal Pardo O, Matarranz M, Torralba M, Galindo Puerto MJ, Rodríguez A, Peñaranda Vera M, Sanjoaquín Conde I, de la Fuente Moral S, Cabello-Úbeda A, Navarro San Francisco C, Antelo Cuéllar K, Pedrosa Aragón M, Aguilera García M, Tiraboschi J, Martínez Álvarez RM, Vivancos MJ, Montero Hernández C, Bernal Morell E, Cabello-Clotet N, Morano Amado LE, Gisbert Pérez L, Sepúlveda MA, Alemán Valls MR, Sánchez Guirao AJ, Fanciulli C, Escrig C, Ferreira Pasos EM, Lucas-Dato A, García Torras S, Hidalgo Tenorio C, Estébanez M, Muelas-Fernandez M, Losa García JE, Cerezales Calviño A, Pino Díaz ME, Martínez Montes C, Arenas García V, Arnaiz de Las Revillas F, Pernas Pardavila H, Padilla S, Garcinuño Jiménez MÁ, Alonso Alonso L, Ramos Vicente N, Barragán Gallo PN, Cabo Magadan R, Del Álamo M, Egido Murciano MV, Juárez Toquero A, Romero Palacios A, Clavero Olmos M, García Navarro MDM, Sanz J, Gainzarain JC, Milian Sanz M, de la Calle B, Ferrero Benéitez OL, Troya J, Buzón-Martín L.

    Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

    Journal of the International AIDS Society . 29(4): .

    [doi:10.1002/jia2.70106]

  • Díaz-Menéndez M, Castilletti C, O'Laughlin K, Itani O, Asgeirsson H, Vázquez González A, Norman FF, Perret C, Rothe C, Deiana M, Malagò S, Corman VM, Equihua Martinez G, Alcedo S, Clark E, Odolini S, Camprubí Ferrer D, Gobbi FG, Hamer DH, Larsen CS, Beisel C, Nnedu O, Pou Ciruelo D, Rodriguez Sevilla G, de la Calle-Prieto F, Emetulu H, Libman M, Trojánek M, Vaughan SD, Huits R.

    Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026: a GeoSentinel analysis.

    Eurosurveillance . 31(16): .

    [doi:10.2807/1560-7917.ES.2026.31.16.2600286]

  • Miján A, Martín O, Ciancas E, Llorente Martín C, Lokoel G, Lokaala S, Lokiriama D, de la Fuente Hernanz S, Llorente de Santiago M, Bertomeu AC, Perez-Molina JA.

    Schistosomiasis in Western Lake Turkana, Kenya: An Exploratory Serosurvey and Validation of Dried Blood Spots for Field Studies.

    Tropical Medicine and Infectious Disease . 11(4): .

    [doi:10.3390/tropicalmed11040091]

  • Navarro-Soler R, Muriel A, Fanciulli C, Bernardino JI, Sáez C, Zamora J, Fernandez-Felix BM, de Morales AGG, Poveda E, de Cea ÁM, Martínez-Sanz J, Moreno S, Serrano-Villar S.

    Towards tuberculosis elimination in people with HIV on antiretroviral therapy: evidence from a two-decade nationwide cohort in Spain.

    Infectious Diseases of Poverty . 15(1): .

    [doi:10.1186/s40249-026-01426-9]

  • Grande-García S, Llamas-Adán M, Crespo-Bermejo C, Lara-Aguilar V, Arca-Lafuente S, Martín-Carbonero L, Ryan P, Santos IL, de Lagarde M, Mican-Rivera R, Moreno S, Resino S, Berenguer J, Briz V, Fernández-Rodríguez A.

    Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance.

    Journal of Infection and Public Health . 19(3): 103108-103108. Nº de citas: 1

    [doi:10.1016/j.jiph.2025.103108]

  • Escrihuela-Vidal F, Larrauri JG, López-Contreras J, Euba G, Vázquez A, Gómez-Zorrilla S, López-Cortés LE, Gasch O, Aparicio-Minguijón E, Escudero-Sánchez R, Pérez-Rodríguez MT, Rodríguez-Pardo D, Jover-Sáenz A, García-Pardo G, Rodríguez-Baño J, Pujol M, Carratalà J, Gutiérrez-Gutiérrez B.

    Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials.

    Lancet Regional Health-Europe . 62: 101611-101611.

    [doi:10.1016/j.lanepe.2026.101611]

  • Watanabe AH, Cano Á, Escudero-Sánchez R, Pesaresi L, Delgado-Iribarren A, Ponz R, Zhou Y, Moreno-Fernandez AM, Galán-Sánchez F, Yücel E.

    Clinical Burden of Carbapenemase-Producing Enterobacterales in Spain: A Multicenter Retrospective Study from Five Hospitals.

    Infection and Drug Resistance . 19: 574515-574515.

    [doi:10.2147/IDR.S574515]

  • Serrano-Villar S, Martín-Pedraza L, Tiraboschi J, Novella M, Cabello-Úbeda A, López-Cortés L, Busca C, Torralba M, Crusells MJ, Hidalgo-Tenorio C, Estrada V, Del Amo-de Palacios A, Díaz de Santiago A, Fons-Contreras M, Santos J, Bernal E, Montero-Alonso M, Troya J, Blanco JR, Burgos J, de Miguel M, Moreno S.

    Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study).

    CLINICAL INFECTIOUS DISEASES . 82(2): . Nº de citas: 5

    [doi:10.1093/cid/ciaf565]

  • García-García JM, Rodrigo-Sanz T, Gullón-Blanco JA, Casas García X, Millet JP, Quirós Fernández S, Martínez Lirola MJ, Mangas Moro A, Domínguez Castellano Á, Navas Elorza E, Nieto Marcos M, Arasa Panisello F, Bermúdez Ruiz P, García Cabrera M, Sanz Herrero F, Suárez Toste I, Urrelo Cerrón LA, Espiau Guarner M, Soriano Arandes A, Arias Guillén M, Cebrián Gallardo JJ, García-Fuertes JA, Pérez-Jacoiste Asín MA, Somoza González M, Palacios Gutiérrez JJ, Alcaide F, Samper Blasco S, Tabernero Huguet E, Caylà JA, Ruiz Manzano J, Caminero Luna JA.

    Rifampicin-resistant tuberculosis in Spain.

    ERJ Open Research . 12(1): .

    [doi:10.1183/23120541.00941-2025]

  • Blanco JR, Torralba M, Saumoy M, Alcaraz A, Del Amo MM, Olalla J, Dronda F, Boukichou-Abdelkader N, Bernal E, Padilla S, Peraire J, Artigues F, Bustinduy-Odriozola MJ, Iglesias HA, Delgado A, Imaz A, Pérez-Martinez L, Cohort CIS.

    Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy.

    PLoS One . 21(2): . Nº de citas: 1

    [doi:10.1371/journal.pone.0343230]

  • Llibre JM, Iniesta C, Tittle V, Clement M, Rivero Á, Armenteros-Yeguas I, Álvarez-López P, Ryan P, Arribas JR, Moreno S.

    Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 81(3): .

    [doi:10.1093/jac/dkag052]

  • Amador C, Ambrosioni J, Martín-Carbonero L, Hidalgo-Tenorio C, Tiraboschi J, Moreno S.

    Bictegravir/emtricitabine/tenofovir alafenamide: A review of the real-world experience in Spain within the last five years.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 44(2): 503056-503056.

    [doi:10.1016/j.eimce.2026.503056]

  • Balsa-Vázquez J, Rubio-Muñoz JM, Duvignaud A, Alcedo S, de Ayala AP, Salas-Coronas J, Elía-López M, Cattaneo P, Arévalo-Cañas C, García-Bujalance S, Ruiz-Giardín JM, Norman FF, Rojo-Marcos G.

    Comparison of routine clinical profiles of patients with imported P. falciparum malaria and co-infection with Plasmodium ovale wallikeri or Plasmodium ovale curtisi.

    ACTA TROPICA . 274: 107982-107982. Nº de citas: 1

    [doi:10.1016/j.actatropica.2026.107982]